Inflammation as a mechanism and therapeutic target for in-stent restenosis

Current Atherosclerosis Reports

Volumn 7, Issue 1, 2005, Pages 44-49

  Drachman, Douglas E ^a   Simon, Daniel I ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN; CHEMOATTRACTANT; CYTOKINE; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PACLITAXEL; PADGEM PROTEIN; PROBUCOL; RAPAMYCIN; STEROID; TRANILAST; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY INTIMA PROLIFERATION; BLOOD VESSEL INJURY; CELL INTERACTION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG ELUTING STENT; DRUG PROTEIN BINDING; DRUG TARGETING; HEALING; HEART VENTRICLE REMODELING; HUMAN; IN-STENT RESTENOSIS; INFLAMMATION; LEUKOCYTE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; THROMBOCYTE; VASCULAR ENDOTHELIUM;

EID: 15444371185     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-005-0074-5     Document Type: Review

References (49)

1. Grunzig AR, Senning A, Siegenthaler WE: Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979, 301:61-68.
2. Mintz GS, Popma JJ, Pichard AD, et al.: Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996, 94:35-43.
3. Post MJ, Borst C, Kuntz RE: The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994, 89:2816-2821.
4. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
5. Libby P, Ridker P, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
6. Cybulsky MI, Gimbrone MA: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
7. Dong ZM, Chapman SM, Brown AA, et al.: The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998, 102:145-152.
8. Cybulsky MI, Iiyama K, Li H, et al.: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107:1255-1262.
9. Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
10. Geng YJ, Libby P: Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995, 147:251-266.
11. Amento E, Ehsani N, Palmer H, et al.: Cytokines positively and negatively regulate intersitial collagen gene expression in human vascular smooth muscle cells. Arteriosclerosis. 1991, 11:223.
12. Libby P, Simon DI: Inflammation and thrombosis: the clot thickens. Circulation 2001, 103:1718-1720.
13. Mach F, Schonbeck U, Bonnefoy JY, et al.: Activation of monocyte/ macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997, 96:396-399.
14. Henn V, Slupsky JR, Grafe M, et al.: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591-594.
15. Libby P, Schwartz D, Brogi E, et al.: A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992, 86:III47-III52.
16. Welt FG, Rogers C: Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22: 769-1776.
17. Simon DI, Chen Z, Seifert P, et al.: Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest 2000, 105:293-300.
18. Rogers C, Edelman ER, Simon DI: A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci U S A 1998, 95:10134-10139.
19. Tanguay JF, Geoffroy P, Sirois MG, et al.: Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb Haemost 2004, 91:1186-1193.
20. Tanaka H, Sukhova GK, Swanson SJ, et al.: Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993, 88:1788-1803.
21. Rogers C, Welt FG, Karnovsky MJ, Edelman ER: Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996, 16: 12-1318.
22. Welt FG, Edelman ER, Simon DI, Rogers C: Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000, 20:2553-2558.
23. Rogers C, Edelman ER: Controlled release of heparin reduces neointimal hyperplasia in stented rabbit arteries: ramifications for local therapy. J Interv Cardiol 1992, 5:195-202.
24. Edelman ER, Karnovsky MJ: Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 1994, 89:770-776.
25. Horvath C, Welt FG, Nedelman M, et al.: Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocyte targeted. Circ Res 2002, 90:488-494.
26. Gaspardone A, Crea F, Versaci F, et al.: Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998, 82: 15-518.
27. Versaci F, Gaspardone A, Tomai F, et al.: Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000, 85:92-95, A8.
28. Kamijikkoku S, Murohara T, Tayama S, et al.: Acute myocardial infarction and increased soluble intercellular adhesion molecule-1: a marker of vascular inflammation and a risk of early restenosis? Am Heart J 1998, 6:231-236.
29. Inoue T, Hoshi K, Yaguchi I, et al.: Serum levels of circulating adhesion molecules after coronary angioplasty. Cardiology 1999, 91:236-242.
30. Ishiwata S, Tukada T, Nakanishi S, et al.: Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J 1997, 133:387-392.
31. Tsakiris DA, Tschopl M, Jager K, et al.: Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999, 142:193-200.
32. Pietersma A, Koffard M, de Wit LE, et al.: Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995, 91:1320-1325.
33. Cipollone F, Marini M, Fazia M, et al.: Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001, 21:327-334.
34. Neumann FJ, Ott I, Gawaz M, et al.: Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 1996, 27: 19-824.
35. Mickelson JK, Lakkis NM, Villarreal-Levy G, et al.: Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 1996, 28: 45-353.
36. Koch W, Bottiger C, Mehilli J, et al.: Association of a CD18 gene polymorphism with reduced risk of restenosis after coronary stenting. Am J Cardiol 2001, 88:1120-1124.
37. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al.: Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996, 94: 098-3102.
38. Farb A, Sangiorgi G, Carter AJ, et al.: Pathology of acute and chronic coronary stenting in humans. Circulation 1999, 99:44-52.
39. Sy MS, Schneeberger E, McCluskey R, et al.: Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity. Cell Immunol 1983, 82:23-32.
40. Clowes AW, Clowes MM: Inhibition of smooth muscle cell proliferation by heparin molecules. Transplant Proc 1989, 21: 700-3701.
41. Simon DI, Xu H, Ortlepp S, et al.: 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol 1997, 17:528-535.
42. Plescia J, Conte MS, VanMeter G, et al.: Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. J Biol Chem 1998, 273: 0372-20377.
43. Altieri DC, Edgington TS: A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol 1988, 141:2656-2660.
44. Cote G, Tardif JC, Lesperance J, et al.: Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and protocol study group. Circulation 1999, 99:30-35.
45. Holmes DR Jr, Savage MP, LaBlanche JM, et al.: Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2000, 106:1243-1250.
46. Suzuki T, Kopia G, Hayashi S, et al.: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001, 104:1188-1193.
47. Drachman DE, Edelman ER, Seifert P, et al.: Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 2000, 36:2325-2332.
48. Straubinger R: Biopharmaceuticals of paclitaxel (Taxol): formulation, activity, and pharmacokinetics. In Taxol: Science and Applications. Edited by Suffness M. Boca Raton, FL: CRC Press; 1995:237.
49. Virmani R, Guagliumi G, Farb A, et al.: Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004, 109:701-705.